| abstract |
Substances inhibiting cell adhesion mediated by adhesion molecules (in particular, VLA-4) which enable the prevention and treatment of inflammatory diseases caused by leukocyte (for example, monocyte, lymphocyte or eosinocyte) infiltration. A group of carboxylic acid derivatives exemplified by a compound represented by the formula (140) and adhesion molecule inhibitors containing the same as the active ingredient |